Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/correction-to-adjuvant-pd-1-inhibitor-versus-high-dose-interferon-2b-QazrXpnkf0
References (0)
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
- Publisher
- Wiley
- Copyright
- © 2022 Wiley Periodicals LLC.
- ISSN
- 1396-0296
- eISSN
- 1529-8019
- DOI
- 10.1111/dth.15975
- Publisher site
- See Article on Publisher Site
Abstract
Li J, Wang J, Li D, et al. Adjuvant PD‐1 inhibitor versus high‐dose interferon α‐2b for Chinese patients with cutaneous and acral melanoma: a retrospective cohort analysis. Dermatologic Therapy. 2021;34(5):e15067.Some of the funding information was incorrect. Guangzhou Health and Family Planning Commission Technology Project (20191A1515011263) should have been Guangdong Basic and Applied Basic Research Foundation with the number 2019A1515011263.We apologize for this error.
Journal
Dermatologic Therapy – Wiley
Published: Dec 1, 2022